Trials / Unknown
UnknownNCT04622397
Local Subfascial and Intramuscular Tranexamic Acid Administration in Pediatric Patient Undergoing Scoliosis Surgery, Double Blind Randomized Control Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 2 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
We hypothesized that local administration of tranexamic acid will minimize blood loss and blood product administration in pediatric patient undergoing scoliosis surgery
Detailed description
Spine surgery in paediatrics is frequently associated with substantial blood loss. Blood product adminestration in children has many complications that are not fully known. There are many modalities currently available to reduce blood loss in pediatric patients. Tranexamic acid is tissue plasminogen activator inhibitor that reduce perioperative blood loss. To date, no studies have investigated effect of local administration of tranexamic acid in pediatric population undergoing scoliosis surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tranexamic acid injection | Local subfascial and intramuscular infiltration will be performed by surgeon at levels of fixation prior to skine incision |
| DRUG | Saline | Local subfascial and intramuscular infiltration will be performed by surgeon at levels of fixation prior to skine incision |
Timeline
- Start date
- 2021-01-10
- Primary completion
- 2021-11-29
- Completion
- 2021-12-29
- First posted
- 2020-11-10
- Last updated
- 2020-11-10
Source: ClinicalTrials.gov record NCT04622397. Inclusion in this directory is not an endorsement.